Skip to main content

Table 3 Age and weight of dogs at enrolment in two clinical field studies in the northern and southern regions of Australia

From: Efficacy and safety of sarolaner (Simparica®) in the treatment and control of naturally occurring flea infestations in dogs presented as veterinary patients in Australia

Characteristic

Northern study

Southern study

Sarolaner

(2–4 mg/kg)

Spinosad

(≥ 30 mg/kg)

Sarolaner

(2–4 mg/kg)

Spinosad

(≥ 30 mg/kg)

(n = 55)

(n = 25)

(n = 50)

(n = 32)

Age (years)

 Mean

4.7

4.8

5.5

5.9

 Range

0.3–14.0

0.5–14.0

0.3–15.0

0.5–14.0

Body weight (kg)

 Mean

18.3

21.6

18.6

14.4

 Range

2.6–50.8

5.8–40.4

1.8–56.0

2.7–38.0